Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with pembrolizumab in early-stage, triple-negative breast cancer. This is an ASCO Meeting ...
Introduction -- National times in a globalizing world -- Saving social time -- From national to uniform time around the globe -- A battle of colonial times -- Comparing time management -- Islamic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results